Dr. Mohammad Asad, MD

Internal Medicine Peoria, IL Male
NPI: 1982910527
Total Payments
$2,120
2024 Payments
$15.81
Companies
14
Transactions
29
Medicare Patients
9,532
Medicare Billing
$3.4M

Payment Breakdown by Category

Education$1,587 (74.9%)
Food & Beverage$532.68 (25.1%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Education $1,587 17 74.9%
Food and Beverage $532.68 12 25.1%

Top Paying Companies

Company Total Records Latest Year
SANOFI-AVENTIS U.S. LLC $397.90 4 $0 (2021)
Astellas Pharma US Inc $392.95 4 $0 (2021)
Alexion Pharmaceuticals, Inc. $343.95 4 $0 (2019)
Celgene Corporation $230.08 2 $0 (2019)
Takeda Pharmaceuticals U.S.A., Inc. $185.24 2 $0 (2019)
GENZYME CORPORATION $138.85 1 $0 (2017)
Lilly USA, LLC $105.95 1 $0 (2022)
E.R. Squibb & Sons, L.L.C. $103.32 5 $0 (2023)
Janssen Biotech, Inc. $99.99 1 $0 (2020)
Incyte Corporation $60.99 1 $0 (2020)

Payment History by Year

Year Amount Transactions Top Company
2024 $15.81 1 CARDIVA MEDICAL, INC. ($15.81)
2023 $77.51 4 E.R. Squibb & Sons, L.L.C. ($64.10)
2022 $145.17 3 Lilly USA, LLC ($105.95)
2021 $297.00 3 Astellas Pharma US Inc ($198.00)
2020 $360.88 4 Janssen Biotech, Inc. ($99.99)
2019 $580.80 6 Alexion Pharmaceuticals, Inc. ($171.00)
2018 $358.19 4 Alexion Pharmaceuticals, Inc. ($172.95)
2017 $284.29 4 GENZYME CORPORATION ($138.85)

All Payment Transactions

29 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
01/30/2024 CARDIVA MEDICAL, INC. CARDIVA VASCADE MVP VVCS 6-12F (Device) Food and Beverage In-kind items and services $15.81 General
Category: DEVICES
09/29/2023 E.R. Squibb & Sons, L.L.C. CAMZYOS (Drug) Food and Beverage Cash or cash equivalent $22.78 General
Category: Cardiovascular
09/13/2023 E.R. Squibb & Sons, L.L.C. CAMZYOS (Drug) Food and Beverage Cash or cash equivalent $21.69 General
Category: Cardiovascular
05/23/2023 Abbott Laboratories ENSITE (Device) Food and Beverage In-kind items and services $13.41 General
Category: Electrophysiology
01/27/2023 E.R. Squibb & Sons, L.L.C. CAMZYOS (Drug) Food and Beverage Cash or cash equivalent $19.63 General
Category: Cardiovascular
09/16/2022 E.R. Squibb & Sons, L.L.C. CAMZYOS (Drug) Food and Beverage Cash or cash equivalent $24.39 General
Category: Cardiovascular
09/06/2022 Lilly USA, LLC — Education In-kind items and services $105.95 General
04/19/2022 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $14.83 General
Category: Cardiovascular
05/28/2021 Astellas Pharma US Inc — Education In-kind items and services $99.00 General
05/10/2021 SANOFI-AVENTIS U.S. LLC JEVTANA (Drug) Education In-kind items and services $99.00 General
Category: Oncology
03/04/2021 Astellas Pharma US Inc — Education In-kind items and services $99.00 General
12/20/2020 Incyte Corporation — Education Cash or cash equivalent $60.99 General
12/15/2020 Janssen Biotech, Inc. IMBRUVICA (Drug) Education In-kind items and services $99.99 General
Category: Oncology
11/06/2020 SANOFI-AVENTIS U.S. LLC JEVTANA (Drug) Education In-kind items and services $99.95 General
Category: Oncology
11/04/2020 Astellas Pharma US Inc — Education In-kind items and services $99.95 General
12/07/2019 Celgene Corporation Pomalyst (Drug) Food and Beverage Cash or cash equivalent $115.85 General
Category: Hematology / Oncology
09/16/2019 Takeda Pharmaceuticals U.S.A., Inc. VELCADE (Drug) Education In-kind items and services $99.00 General
Category: Oncology
09/13/2019 Alexion Pharmaceuticals, Inc. SOLIRIS (Drug) Education In-kind items and services $99.00 General
Category: Immunology
09/03/2019 Astellas Pharma US Inc — Education In-kind items and services $95.00 General
08/30/2019 Alexion Pharmaceuticals, Inc. SOLIRIS (Drug) Education In-kind items and services $72.00 General
Category: Immunology
04/02/2019 SANOFI-AVENTIS U.S. LLC JEVTANA (Drug) Education In-kind items and services $99.95 General
Category: ONCOLOGY
10/29/2018 Alexion Pharmaceuticals, Inc. SOLIRIS (Drug) Education In-kind items and services $99.00 General
Category: Immunology
10/29/2018 Alexion Pharmaceuticals, Inc. SOLIRIS (Drug) Education In-kind items and services $73.95 General
Category: Immunology
10/10/2018 SANOFI-AVENTIS U.S. LLC JEVTANA (Drug) Education In-kind items and services $99.00 General
Category: ONCOLOGY
08/16/2018 Takeda Pharmaceuticals U.S.A., Inc. VELCADE (Drug) Education In-kind items and services $86.24 General
Category: Oncology
12»

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 86 4,729 168,079 $7.4M $1.6M
2022 85 4,102 123,573 $7.6M $1.7M
2021 19 701 1,237 $147,385 $31,091
Total Patients
9,532
Total Services
292,889
Medicare Billing
$3.4M
Procedure Codes
190

All Medicare Procedures & Services

190 procedure records from CMS Medicare Utilization — Page 1 of 8

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
J9271 Injection, pembrolizumab, 1 mg Office 2023 26 12,400 $1.8M $527,965 29.4%
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj Office 2023 15 6,480 $693,000 $239,287 34.5%
J9299 Injection, nivolumab, 1 mg Office 2023 12 7,900 $655,700 $186,982 28.5%
J0897 Injection, denosumab, 1 mg Office 2023 43 8,280 $463,680 $152,320 32.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 231 606 $190,284 $56,655 29.8%
78815 Nuclear medicine study from skull base to mid-thigh with ct scan Office 2023 45 49 $330,750 $52,628 15.9%
J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg Office 2023 12 1,570 $167,990 $46,676 27.8%
96413 Administration of chemotherapy into vein, 1 hour or less Office 2023 156 356 $239,944 $33,831 14.1%
Q5119 Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg Office 2023 11 1,420 $326,600 $33,699 10.3%
J1439 Injection, ferric carboxymaltose, 1 mg Office 2023 40 36,700 $146,800 $32,441 22.1%
J9217 Leuprolide acetate (for depot suspension), 7.5 mg Office 2023 45 163 $96,333 $21,900 22.7%
Q5122 Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg Office 2023 13 228 $230,508 $21,717 9.4%
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Office 2023 45 50 $46,300 $20,861 45.1%
J2506 Injection, pegfilgrastim, excludes biosimilar, 0.5 mg Office 2023 14 252 $196,812 $19,613 10.0%
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Office 2023 69 50,490 $252,450 $19,488 7.7%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 109 109 $74,229 $18,094 24.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 148 226 $50,398 $13,814 27.4%
74177 Ct scan of abdomen and pelvis with contrast Office 2023 79 83 $248,087 $13,513 5.4%
Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units Office 2023 11 1,670 $75,150 $10,208 13.6%
80053 Blood test, comprehensive group of blood chemicals Office 2023 249 786 $65,238 $8,076 12.4%
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count Office 2023 260 969 $60,078 $7,325 12.2%
36415 Insertion of needle into vein for collection of blood sample Office 2023 241 831 $21,606 $6,980 32.3%
71260 Ct scan of chest with contrast Office 2023 110 117 $265,941 $6,265 2.4%
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less Office 2023 94 133 $45,220 $6,193 13.7%
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less Office 2023 107 290 $43,500 $6,146 14.1%
123…8»

About Dr. Mohammad Asad, MD

Dr. Mohammad Asad, MD is a Internal Medicine healthcare provider based in Peoria, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/20/2010. The National Provider Identifier (NPI) number assigned to this provider is 1982910527.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohammad Asad, MD has received a total of $2,120 in payments from pharmaceutical and medical device companies, with $15.81 received in 2024. These payments were reported across 29 transactions from 14 companies. The most common payment nature is "Education" ($1,587).

As a Medicare-enrolled provider, Asad has provided services to 9,532 Medicare beneficiaries, totaling 292,889 services with total Medicare billing of $3.4M. Data is available for 3 years (2021–2023), covering 190 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Internal Medicine, Internal Medicine
  • Location Peoria, IL
  • Active Since 08/20/2010
  • Last Updated 10/04/2023
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1982910527

Products in Payments

  • JEVTANA (Drug) $397.90
  • SOLIRIS (Drug) $343.95
  • VELCADE (Drug) $185.24
  • MOZOBIL (Drug) $138.85
  • Pomalyst (Drug) $115.85
  • Revlimid (Drug) $114.23
  • IMBRUVICA (Drug) $99.99
  • CAMZYOS (Drug) $88.49
  • RELISTOR (Drug) $19.40
  • CARDIVA VASCADE MVP VVCS 6-12F (Device) $15.81
  • ELIQUIS (Drug) $14.83
  • ENSITE (Device) $13.41
  • JARDIANCE (Drug) $11.81

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Peoria

Dr. Minesh Rajpal, Md, MD

Internal Medicine — Payments: $298,704

Internal Medicine $298,704

Sunitha Nair, Md, MD

Internal Medicine — Payments: $159,450

Internal Medicine $159,450

Umar Waheed, Md, MD

Internal Medicine — Payments: $155,492

Internal Medicine $155,492

Dr. Vimalkumar Veerappan Kandasamy, Md,, MD,

Internal Medicine — Payments: $18,505

Internal Medicine $18,505

Dr. Amit Mehrotra, M.d, M.D

Internal Medicine — Payments: $15,998

Internal Medicine $15,998

Dr. Ashish Sachdeva, Md, MD

Internal Medicine — Payments: $15,062

Internal Medicine $15,062